Regulatory & Legal

AI identity firm Trust Stamp unveils a bold 2026 plan, targeting acquisitions, African markets, and the stablecoin economy to fuel its global expansion.

Investors sue medical device maker Integer Holdings, alleging misleading statements led to a catastrophic 32% stock drop. What went wrong behind the scenes?

The safety giant is launching its 35-2X Series gas ignition controls, targeting Europe and APAC's booming HVAC, ag, and cooking equipment markets.

Shanghai's AI EdTech innovator Jinxin faces a potential Nasdaq delisting after its stock plummets, putting its high-tech vision against market reality.

Over 1,100 groups are fighting to save federal funding for walking and biking, warning of dire safety and economic consequences if key programs are cut.

A state-funded grant unites UCLA and industry to create a scientific benchmark for cannabis flavors, aiming to enhance public safety and regulatory clarity.

A new FAIR Health report finds 57.5% of commercially insured Americans have a chronic condition, with costs nearly doubling for patients with just one.

AI robotics firm Realbotix sells its legacy crypto domain portfolio for $2.245M to an unexpected buyer: the new Bed Bath & Beyond, signaling a major Web3 push.

HearingLife's new Oticon Zeal uses a brain-inspired AI to deliver crystal-clear sound in an invisible design, changing how we treat hearing loss.

Canadian provider Airmedic secures a top European accreditation, validating its high standards in safety and patient care for international medical flights.

A life-changing treatment for a rare kidney disease is now easily accessible in France, ending a long wait for patients and bolstering a French pharma firm.

A lawsuit seeks to block drastic cuts to Florida's ADAP program, which could strip thousands of life-saving HIV medication and insurance by March 1.

The Corrections Center of Northwest Ohio lauds a smooth healthcare transition, but its new partner, Armor Health, brings a history of lawsuits and financial turmoil.

With an extra $3M, Aduro Clean Technologies advances its game-changing plant, turning investor confidence into a reality for recycling and energy.

Shane Kovacs's exit from Olema Oncology introduces leadership questions as the biotech firm nears a pivotal data readout for its lead breast cancer drug.

Corcept Therapeutics' stock plummeted and it now faces legal probes after the FDA rejected its key drug, revealing the company was warned not to apply.

A massive Texas pilot with 41,000 drivers proves smartphones can replace the gas tax. Is this the future of funding America's crumbling roads?

Canada's largest veteran group issues a rare rebuke of a US President, defending the nation's Afghanistan sacrifice and praising PM Carney's stand on sovereignty.

With key proposals at risk due to low voter turnout, Plug Power faces a forced reverse stock split, creating a high-stakes showdown with its investors.

A new initiative from the Center for Educational Innovation aims to tackle the workforce readiness gap with AI, robotics, and teacher leadership training.